Human iPSC-derived PD-cell models were later used to have a mechanistic insight into the gene-environmental interaction involved in the pathogenesis of PD, such as the use of small-molecule high-throughput screening to identify new pathways (like MEF2C-PGC1α pathway) as therapeutic targets to combat PD (Ryan et al., 2013). Here, MEF2C is linked to Parkinson disease.